|
You
are here: Home: San
Antonio Breast Cancer Symposium
San Antonio Breast Cancer Symposium Clinical
Trials Exhibit
Increasing Statistical Power in
Breast Cancer Clinical Trials
Research To Practice: Breast-conserving
Surgery
Research To Practice: Adjuvant
Systemic Therapy
Barriers to Clinical Trial Accrual
NCI Trial Programs: Clinical Trials
Support Unit (CTSU)
ATAC: A Novel International Model
for Clinical Trial Accrual
Anastrozole, Tamoxifen, Alone
or in Combination (ATAC)
Adjuvant Endocrine Therapy Trials
in Postmenopausal Patients
Ductal Carcinoma In Situ (DCIS):
NSABP B-35, IBIS-2 Trials
Adjuvant Endocrine Therapy Trials
in Premenopausal Patients
Optimal Neoadjuvant Endocrine
Therapy
Fulvestrant: An Endocrine Agent
with a Unique Mechanism of Action
Key Second-generation Trials
of Adjuvant Taxanes
Capecitabine/Docetaxel: A Rationally
Derived Combination
Dose-dense Adjuvant Chemotherapy
Neoadjuvant Chemotherapy
CALGB 49907: Adjuvant Chemotherapy
in Elderly Women
Biologic Therapies Combined with
Chemo/hormonal Agents
Management of the Axilla
Radiation Therapy for Primary
Breast Cancer
Adjuvant Bisphosphonates
Clinical Trials of Adjuvant Trastuzumab
Breast Cancer Clinical Trials
in Elderly Women
Clinical Trials of Breast Cancer
Chemoprevention
|
